PCOS Symptoms: Recognizing the Signs of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders affecting women of reproductive age, yet it remains significantly underdiagnosed. According to the World Health Organization, an estimated 10 to 13 percent of women globally have PCOS, but up to 70 percent of affected women remain undiagnosed. Understanding the symptoms of PCOS is essential for early detection and management of this complex condition that affects multiple body systems.

What Is PCOS?

Polycystic ovary syndrome is a hormonal imbalance that occurs when the ovaries produce unusually high levels of androgens, often referred to as male hormones, though they are present in all women. This hormonal disruption causes reproductive hormones to become imbalanced, leading to a range of symptoms affecting menstruation, fertility, metabolism, and physical appearance.

Despite its name, having polycystic ovaries is not required for a PCOS diagnosis. The condition is now understood as a complex metabolic and reproductive disorder with far-reaching effects beyond the ovaries. According to current diagnostic guidelines, PCOS is diagnosed when at least two of the following three criteria are present: clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovaries on ultrasound or elevated anti-Mullerian hormone levels.

Research indicates that PCOS is the most common endocrine disorder among females of reproductive age worldwide, affecting approximately 5 million reproductive-aged women in the United States alone. The condition often develops during adolescence around the time of the first menstrual period, though some women do not discover they have PCOS until they experience difficulty becoming pregnant.

Menstrual Irregularities

One of the hallmark symptoms of PCOS is irregular menstrual periods. The hormonal imbalances characteristic of PCOS interfere with normal ovulation, which in turn disrupts the menstrual cycle. Women with PCOS may experience several types of menstrual irregularities.

Many women with PCOS have fewer than eight menstrual periods per year, a condition known as oligomenorrhea. Some may go months without a period, while others may experience amenorrhea, the complete absence of menstruation. When periods do occur, they may be unpredictable, making it difficult to anticipate when the next cycle will begin.

Conversely, some women with PCOS experience very heavy menstrual bleeding when they do have a period. This occurs because the uterine lining, or endometrium, continues to build up during the extended time between periods. When menstruation finally occurs, the thickened lining can result in prolonged or unusually heavy bleeding.

PCOS is diagnosed in approximately 80 percent of patients with oligomenorrhea and up to 30 to 40 percent of patients presenting with primary or secondary amenorrhea. These menstrual irregularities are often the first noticeable symptom that prompts women to seek medical attention.

Skin and Hair Changes

The elevated androgen levels in PCOS frequently manifest as visible changes in skin and hair. These symptoms, while not dangerous, can significantly impact quality of life and self-esteem.

Hirsutism

Hirsutism, or excess hair growth in areas where men typically grow hair, affects up to 70 percent of women with PCOS. This includes the face, particularly the chin and upper lip, as well as the chest, back, and abdomen. The hair growth is often coarse and dark, differing from the fine vellus hair that normally covers these areas.

Acne

PCOS-related acne tends to be persistent and difficult to treat. It commonly appears on the face, back, and chest, and may continue well past the teenage years when hormonal acne typically resolves. This acne is driven by the excess androgens stimulating the sebaceous glands to produce more oil.

Thinning Scalp Hair

While women with PCOS often experience excess hair growth on the body, they may simultaneously experience thinning hair on the scalp. This pattern, sometimes called androgenic alopecia, typically presents as a widening part or overall thinning at the crown of the head, similar to male-pattern baldness. The same elevated androgens that cause hirsutism can miniaturize hair follicles on the scalp.

Weight and Metabolic Symptoms

The relationship between PCOS and metabolism is complex and bidirectional. Weight and metabolic symptoms are among the most challenging aspects of the condition to manage.

Weight Gain and Difficulty Losing Weight

Between 40 and 80 percent of women with PCOS have obesity and struggle to maintain a healthy weight. Weight gain associated with PCOS tends to concentrate in the midsection, creating what is often described as an apple-shaped body. This central adiposity is particularly concerning because abdominal fat is more metabolically active and associated with greater health risks.

Women with PCOS often find it exceptionally difficult to lose weight despite following the same diet and exercise regimens that work for others. Research has revealed a complex metabolic picture in which hyperandrogenemia promotes visceral adiposity and alters muscle metabolism, thereby exacerbating insulin resistance. Conversely, insulin resistance stimulates ovarian and adrenal androgen production through multiple mechanisms, creating a self-perpetuating cycle that makes weight loss challenging.

Insulin Resistance

Insulin resistance is the most prevalent metabolic abnormality in patients with PCOS and is closely related to disease progression and severity. Approximately 33 to 66 percent of patients with PCOS have an abnormal degree of insulin resistance, regardless of body weight.

When cells become resistant to insulin, the pancreas produces more insulin to compensate. This hyperinsulinemia further promotes fat storage and weight gain, while also stimulating the ovaries to produce more androgens. The resulting cycle of insulin resistance, weight gain, and elevated androgens can be difficult to break without targeted intervention.

A paradigm shift in understanding PCOS now emphasizes the central role of hyperinsulinemia and insulin resistance. The traditional glucose-focused approach has led to delayed diagnosis of progressive metabolic and reproductive consequences, leaving many patients underdiagnosed and undertreated. Recognizing signs of diabetes risk is particularly important for women with PCOS.

Fertility and Reproductive Health

PCOS is the most common cause of anovulatory infertility, accounting for 70 to 80 percent of infertility cases related to lack of ovulation. The hormonal imbalances that characterize PCOS disrupt the normal monthly release of eggs from the ovaries.

In a typical menstrual cycle, rising levels of follicle-stimulating hormone cause follicles in the ovary to develop, with one becoming dominant and releasing a mature egg. In PCOS, this process is disrupted. Follicles may begin to develop but fail to mature fully, often remaining as small cysts on the ovaries visible on ultrasound. Without ovulation, pregnancy cannot occur naturally.

However, having PCOS does not mean pregnancy is impossible. Current treatment guidelines recommend lifestyle changes as the first-line treatment for PCOS-related infertility. Modest weight loss of just 5 percent of body weight, with improvement in insulin sensitivity, frequently results in clinically meaningful improvements in hyperandrogenic, reproductive, and metabolic features.

When lifestyle modifications are insufficient, medical treatments can help induce ovulation. According to the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, letrozole is now the preferred first-line pharmacological infertility therapy. Clomiphene citrate combined with metformin, gonadotropins, or laparoscopic ovarian surgery serve as second-line options. In vitro fertilization may be offered as a third-line therapy when other approaches have not succeeded.

Other Symptoms

Beyond the primary symptoms, PCOS is associated with several additional manifestations that may not immediately seem connected to a hormonal disorder.

Skin Changes

Acanthosis nigricans, or darkening of the skin, commonly appears in body folds such as the neck, armpits, groin, and under the breasts. This velvety, darkened skin is a visible sign of insulin resistance and high insulin levels. Small, fleshy skin tags may also develop, particularly in the armpits and neck area.

Mood Changes

Women with PCOS have higher rates of depression and anxiety compared to women without the condition. The exact mechanisms are not fully understood but likely involve a combination of hormonal factors, the psychological impact of visible symptoms like acne and hirsutism, and the metabolic disturbances associated with the condition. Understanding the connection between anxiety and mood changes can help women with PCOS seek appropriate support.

Fatigue

Many women with PCOS report persistent fatigue that interferes with daily activities. This chronic fatigue may be related to the metabolic dysfunction, disrupted sleep, mood disturbances, or a combination of these factors. Blood sugar fluctuations associated with insulin resistance can also contribute to energy levels that rise and fall unpredictably throughout the day.

Sleep Apnea

Obstructive sleep apnea occurs at higher rates in women with PCOS. This condition, in which breathing repeatedly stops and starts during sleep, is associated with the metabolic changes and weight gain common in PCOS. Symptoms of sleep apnea include loud snoring, gasping during sleep, morning headaches, and excessive daytime sleepiness. Untreated sleep apnea can worsen insulin resistance and contribute to cardiovascular risk.

Long-Term Health Risks

PCOS is a lifelong condition with implications that extend far beyond reproductive health. Awareness of these long-term risks underscores the importance of early diagnosis and ongoing management.

Type 2 Diabetes

The insulin resistance that characterizes PCOS significantly increases the risk of developing type 2 diabetes. Approximately 25 to 30 percent of women with PCOS will show impaired glucose tolerance by the age of 30, and 8 percent of affected women will develop type 2 diabetes annually. By age 40, up to 40 percent of women with PCOS have some level of abnormal glucose tolerance.

Cardiovascular Disease

Cross-sectional and longitudinal studies confirm that women with PCOS have an increased risk of cardiovascular events, including myocardial infarction, ischemic heart disease, and stroke. This elevated risk is related to higher rates of obesity, high blood pressure, high cholesterol, and metabolic syndrome in the PCOS population. These cardiovascular risks exist independently of obesity, meaning even lean women with PCOS face elevated risk.

High Blood Pressure

Hypertension is more prevalent among women with PCOS and contributes to the overall cardiovascular risk profile. The mechanisms likely involve insulin resistance, increased sympathetic nervous system activity, and effects of androgens on blood vessels.

Endometrial Cancer

The chronic absence of ovulation in PCOS means the uterine lining is exposed to estrogen without the protective effects of progesterone that normally follow ovulation. This unopposed estrogen stimulation causes the endometrium to thicken progressively, increasing the risk of endometrial hyperplasia and endometrial cancer. Research has identified PCOS in 31.2 percent of endometrial cancer patients under 40 years old, highlighting the strong correlation between these conditions.

When to See a Doctor

Women should consult a healthcare provider if they experience any combination of the following symptoms that may suggest PCOS:

Irregular menstrual periods, especially fewer than eight periods per year or cycles longer than 35 days, warrant evaluation. This is particularly important when accompanied by other symptoms such as excess facial or body hair, persistent acne that does not respond to typical treatments, or unexplained weight gain, especially around the midsection.

Difficulty becoming pregnant is another important reason to seek medical attention. Since PCOS is the leading cause of anovulatory infertility, early evaluation can lead to effective treatment and improved chances of conception.

Women who notice signs of elevated blood sugar, such as increased thirst, frequent urination, or unexplained fatigue, should discuss screening for diabetes with their healthcare provider. The strong association between PCOS and insulin resistance makes regular metabolic monitoring essential.

Early diagnosis of PCOS allows for interventions that can improve quality of life, enhance fertility, and reduce the risk of long-term complications. Given that up to 70 percent of women with PCOS remain undiagnosed, increasing awareness of these symptoms is crucial for improving health outcomes.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any medical condition. The information presented here should not be used as a substitute for professional medical care.

References

1. World Health Organization. Polycystic ovary syndrome fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome

2. Cleveland Clinic. PCOS (Polycystic Ovary Syndrome): Symptoms & Treatment. https://my.clevelandclinic.org/health/diseases/8316-polycystic-ovary-syndrome-pcos

3. Mayo Clinic. Polycystic ovary syndrome (PCOS) - Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439

4. National Center for Biotechnology Information. Polycystic Ovarian Syndrome - StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK459251/

5. American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

6. Frontiers in Endocrinology. Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1669716/full

7. Journal of Clinical Medicine. Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model. https://www.mdpi.com/2077-0383/14/12/4021

8. PubMed Central. Long term health consequences of polycystic ovarian syndrome: a review analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC2683463/